Jiangsu Kanion Pharmaceutical Co., Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jiangsu Kanion Pharmaceutical Co., Ltd. with three other
companies in this sector in China:
Jiangzhong Pharmaceutical Company Limited
sales of 2.60 billion Chinese Renmimbi [US$376.94 million]
of which 68%
was Medical Industry),
Harbin Gloria Pharmaceuticals Co., Ltd
(2.70 billion Chinese Renmimbi [US$392.05 million]
of which 85%
was Pharmaceutical Manufacturing), and
Shanghai Shyndec Pharmaceutical Co Ltd
(2.68 billion Chinese Renmimbi [US$389.44 million]
of which 74%
was Drug Products).
During the year ended December of 2015, sales at
Jiangsu Kanion Pharmaceutical Co., Ltd. were 2.82 billion Chinese Renmimbi (US$409.52 million).
increase of 10.0%
versus 2014, when the company's sales were 2.56 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Jiangsu Kanion Pharmaceutical Co., Ltd.
(and since 2010, sales have increased a total of 108%).
Sales of Exportation Trade saw an increase
10.1% in 2015, from
2.56 billion Chinese Renmimbi to 2.82 billion Chinese Renmimbi.
Not all segments of Jiangsu Kanion Pharmaceutical Co., Ltd. experienced an increase in sales in 2015:
sales of Other Operations fell 18.3% to 3.51 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).